| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |